Safety and Tolerability of Antiretrovirals during Pregnancy

Table 1

Demographics and baseline characteristics of HIV infection.

Characteristic	𝑁 or Median (% or IQR)
Pregnant patients	105
One pregnancy with CHIP	93 (89)
Two pregnancies with CHIP	12 (11)
Maternal age at delivery	30 (26, 34)
Race
White	72 (68.6)
Black	31 (29.5)
Other	2 (1.9)
Ethnicity
Hispanic	41 (39)
Not hispanic	64 (61)
HIV risk factors†
IV drug use	12 (11)
Heterosexual sex	98 (92)
Transfusion	5 (5)
Timing of HIV diagnosis
Prior to first pregnancy at CHIP	70 (67)
During first pregnancy at CHIP	35 (33)
Antiretroviral therapy at the onset of pregnancy	29 (25)
Plasma HIV RNA at first visit	109 pregnancies
Median (quartiles)	2657 (225, 16700)
>400 copies/mL	78 (72)
CD4+ count at first visit	108 pregnancies
Median (quartiles)	450 cells/μL (269, 628)
<200 cells/μL	13 (12%)

†Some subjects had multiple risk factors.